Oracle's stock fell 5% after the company revealed that layoff costs increased by $700 million due to severance and AI-related workforce reductions, overshadowing Executive Chair Larry Ellison's canceled plan to sell $7.5 billion in shares. The negative reaction also affected AI infrastructure peers CoreWeave and Nebius, which dropped 5% each, reflecting broader concerns about the sustainability of hyperscale AI spending. Oracle is funding its data center expansion through debt and share issuance amid negative free cash flow, raising financing concerns despite Ellison's insider vote of confidence. Investors will watch for further clarity on restructuring costs and AI demand to gauge the stock's outlook.
Larry Ellison, Oracle's founder, canceled a plan to sell up to $7.5 billion in Oracle shares just one day after it was publicly disclosed. This move follows a dramatic $200 billion decline in his net worth over the past year, largely due to Oracle's ...
Oracle Health has introduced the Clinical AI Agent for nurses in the U.S., integrating AI-powered voice navigation, acute nursing summaries, and voice-enabled charting into its EHR system. This tool helps nurses quickly access patient information, do...
Oracle co-founder Larry Ellison has canceled his plan to sell up to 50 million Oracle shares, worth about $7.5 billion, which was set to expire in October. No shares were sold under this plan, and Ellison has no other plans to sell his stock. Oracle'...
Larry Ellison, Oracle's controlling shareholder, canceled a planned $7.5 billion stock sale, signaling his confidence in the company's future amid strong AI cloud growth. The cancellation removes selling pressure as Oracle's stock had fallen about 16...
Larry Ellison, Oracle's founder, has canceled his plan to sell up to 50 million shares worth $7.5 billion. The plan was disclosed in a recent regulatory filing but no shares were sold under it. Ellison still controls more than 40% of Oracle, which he...
